SAMUEL D. COLELLA

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SAMUEL D. COLELLA:

Company Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By Colella Partners
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By Colella Partners II
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By spouse
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By the Colella Family Exempt Marital Deduction Trust
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By the Colella Family Trust
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By Versant Development Fund III, LLC
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By Versant Side Fund III
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 By Versant Venture Capital III L.P.
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 Direct
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 The Samuel Colella Trust
Flexion Therapeutics Inc Director Stock option (right to buy) 0 19 Nov 2021 Direct

Insider Reports Filed by SAMUEL D. COLELLA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919121065716-colella-samuel-d-2021-11-19 Flexion Therapeutics Inc 19 Nov 2021 18 -$12,720,794 4 Director 19 Nov 2021, 09:12
/report/000120919121043553-colella-samuel-d-2021-06-24 Flexion Therapeutics Inc 24 Jun 2021 2 $0 4 Director 28 Jun 2021, 18:32